Insights

FUGO Precision 3D Integrates Graphy Materials for High-Precision Dental Manufacturing

FUGO Precision 3D Integrates Graphy Materials for High-Precision Dental Manufacturing

January 12, 2026 Medical

FUGO Precision 3D, a developer of 3D printing technology for dental manufacturing, has announced a strategic collaboration with South Korea’s Graphy, a developer of photopolymer materials for 3D printing, ahead of its official market debut at LMT Lab Day 2026 in Chicago. The partnership will integrate Graphy’s advanced photopolymer materials into FUGO’s centrifugal 3D printing platform, creating a streamlined, high-precision workflow for dental applications.

Read More

News

We realize your creation

FacFox provides one-stop solution with comprehensive on-demand manufacturing capabilities and data-driven analysing technologies, see our available service, feel free to reach us to realize your creation!

Most Viewed

On the precipice of expansion: a conversation with LOOP 3D Decision Makers

LOOP 3D is a 3D printer manufacturer based in Ankara, Turkey, which brought to market the LOOP PRO extrusion-based 3D printing system late last year. The young company is now preparing to expand into the European market with the opening of an office in Wroclaw, Poland. At this pivotal time of growth for the company, we caught up with Mehmet Erkan Ustaoğlu, Founder and CEO of LOOP 3D, and Anna Bogusz, EMEA Sales Manager of LOOP 3D.

32f9e2b1ed35ab7223d4ca0c0ebecdb7.jpg

Made In Space’s VULCAN to be further developed under new NASA contract Aerospace

As additive manufacturing technologies continue to evolve here on Earth, they are also moving steadily ahead in outer space, due in large part to American company Made In Space. The company, which in 2016 sent the first 3D printer into space to be used aboard the International Space Station (ISS), has now won a contract from NASA to continue developing VULCAN, its next-generation metal space manufacturing system.

DDD Focuses on Healthcare after Solid-Organ Scaffolds’ Success

DDD Focuses on Healthcare after Solid-Organ Scaffolds’ Success

3D Systems significantly expanded its focus on regenerative medicine and bioprinting solutions after reducing its workforce to concentrate on the healthcare AM sector. The expanded focus follows on great progress made in the development of 3D printing systems for solid-organ scaffolds. This progress is the product of collaboration between 3D Systems, United Therapeutics Corporation and UTC’s organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC. 3D Systems intends to leverage this work and accomplishments with other partners to invest, further develop and commercialize solutions for regenerative medicine. Applications of its R&D program include the development of non-solid organ applications requiring biologically sustainable vasculature.